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Selected nutritional risk parameters  
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— a comparison with other patients  
hospitalized in a Department of Laryngology 
and patients with colorectal cancer
ABSTRACT
Background: It is assumed that neoplasm greater in size may affect a patients’ nutritional status and prog-
nosis stronger than smaller one. The aim of this study was to compare the nutritional status and prognosis 
of patients with laryngeal cancer (LC), recognized as tumour smaller in size, and patients with colorectal 
cancer (CRC) who were hospitalized in our hospital during the one year period. 
Methods: The retrospective review of medical documentation of all 1,134 patients hospitalized in a De-
partment of Otolaryngology. 
Results: The laryngeal tumour was smaller than colorectal. Nutritional risk concerned 9% of patients with 
LC, was greater than in patients with other laryngeal disorders (1.4%), and lower than in patients with 
CRC (37%). A Nutritional Risk Screening (NRS) 2002 score ≥ 3 was the only significant factor influencing 
the risk of in-hospital all-cause mortality, 14- and 30-day readmissions in patients with LC, and the risk of 
14-day rehospitalization in patients with CRC. 
Conclusions: Risk of malnutrition in patients with LC was lower than in counterparts with CRC, and con-
cern 9% and 37% of patients, respectively. Nutritional risk diagnosed in patients with LC had a stronger 
association with the prevalence of the measured outcomes (in-hospital death, the risk of 14-day and 
30-day readmission, length of hospitalization) than in individuals with CRC. 
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Introduction
Malnutrition and cachexia are common disorders in 
patients with cancer. Among individuals with neoplasms 
of the head or larynx, these disorders affect about 
35–50% of patients [1]. Malnutrition is an important 
risk factor for in-hospital mortality, rehospitalization, 
prolonged general inpatient hospital stays [2], as well 
as the incidence of complications [1, 3, 4]. In patients 
treated for laryngeal cancer (LC), these complications 
include immunodeficiencies, poor wound healing, 
wound infection, anastomotic leakage, fistula, respi-
ratory insufficiency, and sepsis. The many nutritional 
risk parameters (e.g. blood concentrations of albumin, 
prealbumin, transferrin, as well as lymphocyte count) 
[5, 6], have been analyzed as factors affecting the out-
comes of LC treatment, but even low body mass index 
(BMI) before surgery was related to poor prognosis in 
patients with squamous laryngeal cancer [7] and indi-
viduals with colorectal cancer (CRC) [8]. The causes of 
malnutrition in these patients were not only associated 
with cancer-related cachexia, but also to local tumour 
effects (e.g. pharyngeal dysphagia, odynophagia and 
ileus), anorexia, and alcoholism [1]. These factors 
may be responsible for greater nutritional risk among 
patients with head and neck cancers compared to neo-
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plasms in other localizations. To check this hypothesis, 
we analyzed the values of some nutritional parameters 
over a one-year period in patients with LC and CRC, 
hospitalized, respectively, in the Departments of Otolar-
yngology and Surgery at our hospital, and compared 
the nutritional risk. 
Patients and methods
We performed an analysis of the medical docu-
mentation of 1,134 patients treated in the Department 
of Otolaryngology and 92 patients with CRC treated in 
the Department of Surgery between July 1st, 2014 and 
June 30th, 2015 in a university hospital. The premise for 
choosing CRC as the counterpart for patients with LC was 
that both neoplasms can affect patients’ nutritional status 
through changes in the functioning of the alimentary tract. 
The following clinical data, nutritional screening 
scores and nutritional assessment parameters were 
evaluated: age, gender, number of days hospitalized, 
hospitalization mode (whether urgent or scheduled), 
in-hospital all-cause mortality, non-elective readmission, 
Nutritional Risk Screening (NRS) 2002 score (a score of 
at least 3 points for the questionnaire indicates a risk of 
malnutrition), body mass, height, BMI, blood concen-
tration of hemoglobin, total cholesterol, low-density 
lipoprotein (LDL) cholesterol, triglycerides, glucose, 
albumin, C-reactive protein (CRP), and absolute lym-
phocyte count. All the biochemical parameters included 
in the analysis were the first determinations during the 
respective hospitalizations. The following secondary 
parameters were also calculated: 
•	 an “ideal weight” was calculated according to 
the Lorentz formula: for female patients, ideal 
weight = [height (cm) — 100] - {[height (cm) 
— 150]/2}; and for male patients, ideal weight = [height 
(cm) - 100] — {[height (cm) - 150]/4} [9];
•	  an “absolute difference between the actual and 
ideal body weight” was calculated according to the 
following formula: actual body mass — ideal weight; 
•	 a “relative difference between actual and ideal body 
weight” was calculated according to the following 
formula: 100 x (actual body mass — ideal weight)/
actual body mass; 
•	 body mass deficit was defined as a negative value 
of the “absolute difference between the actual and 
ideal body weight”; 
•	 the Nutritional Risk Index (NRI) was calculated 
according to the following formula: NRI = 1.519 x 
blood albumin concentration (g/l) + 41.7 x actual 
body mass/ideal body mass [9,10];
•	 Onodera’s (Preoperative) Prognostic Nutritional 
Index (OPNI) was calculated as 10 × serum albumin 
concentration (g/dl) + 0.005 × lymphocyte count 
(per mm3) [11–15];
•	 blood CRP/albumin ratio.
The above acted as nutritional screening scores and 
nutritional assessment parameters [2]. 
The diagnosis of cancerous and non-cancerous 
disease in the respective patients was determined ac-
cording to the ICD-10 Classification of Diseases. The 
LC and CRC staging was assessed according to the 7th 
edition of the Cancer Staging Manual of the American 
Joint Committee on Cancer [16]. 
Measured outcomes
The following outcomes were measured: hospital 
length of stay (LOS; the number of days hospitalized), 
in-hospital all-cause mortality, and non-elective read-
mission (the second and subsequent hospitalizations 
during the period analyzed) in the 14-day and 30-day 
periods following discharge. 
Bioethics
The investigation was conducted in compliance with 
the Declaration of Helsinki for medical research. 
Statistics
Statistical analysis was conducted using licensed 
versions of STATISTICA statistical software (a data 
analysis software system), StatSoft, Inc. (2017), ver-
sion 13.1. The normal distribution of the study vari-
ables was checked using the Shapiro-Wilk test. The 
results were mainly presented as the mean ± stan-
dard deviation (SD), or n, %. The statistical signifi-
cance of differences between groups was verified us-
ing the Student’s t-test and Chi2 test. Spearman rank 
correlation was also used. The statistical significance 
level was set at a p-value < 0.05. The odds ratio (OR) 
was defined as the odds that an outcome will occur 
with the association of some value of an estimated 
variable (a clinical or biochemical parameter), com-
pared to the odds of the outcome occurring in the 
absence of that association. The OR was calculated 
according to the following formula: the product of the 
number of subjects with the measured outcome and 
the presence of the variables analyzed (exposed cas-
es) and the number of subjects without the presence 
of the variables analyzed (unexposed non-cases) 
divided by the product of the numbers of exposed 
non-cases and unexposed cases. For this purpose, 
we used free statistical calculators (e.g. https://www.
medcalc.org/calc/odds_ratio.php). These analyses 
were performed both per hospitalization and per 
patient. 
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Table 1. Demographic and clinical data of the patients analyzed 
Feature Patients with  
laryngeal cancer
(n = 33)
Patients in the Department  
of Laryngology without  
a diagnosis of laryngeal  
cancer (n = 1,101)
Patients with 
colorectal cancer
(n = 92)
Age (years) 62.0 ± 10.9 47.3 ± 18.6 + 69.3 ± 11.3 +
Age ≥ 65 years (n, %) 13 (39.4%) 201 (18.3%) + 82 (89.1%) +
Male gender (n, %) 31 (93.9%) 602 (54.7%) + 65 (70.7%) +
Tumor size (cm) 2.74 ± 1.02 4.52 ± 2.69 +
Neoplastic disease stage
I (n, %) 9 (27.3%) 28 (30.4%)
II (n, %) 5 (15.1%) 20 (21.7%)
III (n, %) 9 (27.3%) 21 (22.8%)
IV (n, %) 10 (30.3%) 23 (25.0%)
Diabetes (n, %) 3 (9.1%) 37 (3.4%) 20 (21.7%) *
Duration of hospitalization (days) 9.6 ± 6.8 3.1 ± 2.9 + 10.7 ± 9.5
In-hospital death (n, %) 1 (3%) 2 (0.18%) * 9 (9.8%) +
Rehospitalization within 14 days (n, %) 1 (3%) 5 (0.45%) 8 (8.7%) +
Rehospitalization within 30 days (n, %) 1 (3%) 13 (1.2%) 13 (14.1%)
Body mass (kg) 77.7 ± 12.3 75.5 ± 17.4 75.90 ± 17.4
Height (cm) 176.9 ± 8.2 170.2 ± 11.6 * 167.1 ± 8.9 +
BMI (kg/m2) 24.9 ± 4.1 25.9 ± 4.9 27.1 ± 5.4 *
Ideal body weight (kg) 69.7 ± 6.7 63.71 ± 9.1 + 61.7 ± 7.4 +
Absolute difference between actual and ideal 
body weight (kg)
8.05 ± 12.3 11.81 ± 13.8 14.3 ± 15.3 *
Relative difference between actual and ideal body 
weight (%)
10.3 ± 14.8 12.5 ± 17.4 15.8 ± 15.6 *
Body mass deficit (n, %) 8 (24.2%) 192 (17.4%) 17 (18.5%)
NRS-2002 score 1.0 ± 1.2 0.2 ± 0.6 + 2.14 ± 1.5 +
NRS-2002 ≥ 3 score 3 (9.1%) 15 (1.4%) * 34 (37.0%) +
NRI 50.1 ± 9.3 54.9 ± 13.5 54.3 ± 11.8
Albumin (g/l) 3.2 ± 0.6 3.3 ± 0.8 3.1 ± 0.8
CRP (mg/dl) 49.4 ± 53.2 64.2 ± 117.9 78.8 ± 75.4
CRP/albumin ratio 19.84 ± 20.9 54.14 ± 99.5 24.6 ± 31.2
Blood lymphocyte count (G/l) 1.7 ± 0.7 2.0 ± 1.0 1.8 ± 2.9
OPNI 31.8 ± 5.6 31.2 ± 9.3 30.9 ± 7.9
Hemoglobin (g/dl) 13.5 ± 2.2 14.0 ± 1.8 11.3 ± 2.5
Cholesterol (mg/dl) 179.1 ± 49.3 190.9 ± 67.0 150.0 ± 60.9
LDL cholesterol (mg/dl) 76.7 ± 10.0 128.3 ± 59.8 105.7 ± 43.7
Triglycerides (mg/dl) 120.7 ± 40.7 126.2 ± 74.5 123.4 ± 67.5
Glucose (mg/dl) 118.2 ± 36.4 108.6 ± 44.7 131.0 ± 50.1
BMI — body mass index; NRS — Nutritional Risk Screening; NRI — Nutritional Risk Index; CRP — C-reactive protein; OPNI — Onodera’s Prognos-
tic Nutritional Index; LDL — low-density lipoprotein. Student’s t-test in relation to patients with laryngeal cancer: * — p < 0.05; + — p < 0.001 
Results
Patients with LC were predominantly male and 
younger than patients with CRC but, on average, old-
er than other patients admitted to the Department of 
Otolaryngology (Tab.1). The tumour size in patients 
with LC was lower than in individuals with CRC. The 
percentages of patients with the respective clinical 
stage of neoplasm were similar (Tab.1). The duration 
of hospitalization of patients with LC was similar to 
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that of patients with CRC. In relation to nutritional risk, 
compared to patients with CRC, patients with LC had 
a significantly lower BMI value, and both a lower ab-
solute and relative difference between actual and ideal 
body weight (Tab.1). They also had lower nutritional risk 
expressed by NRS-2002 score and a lower prevalence 
of an NRS-2002 score ≥ 3. However, the remaining 
biochemical parameters of nutritional status did not 
differ in patients with LC compared with those with CRC. 
In patients with LC, the number of hospitalization 
days correlated significantly and positively with NRS-
2002 score (R = 0.47; p = 0.006); however, in patients 
with CRC, the length of hospital stay was significantly 
associated with patients’ age (R = 0.21; p = 0.022), 
hyperglycemia (blood concentration of triglycerides 
greater than 200 mg/dl) on admission (R = 0.34; 
p = 0.016), NRS-2002 score (R = 0.39; p = 0.0001), 
and body weight deficit (R = 0.21; p = 0.039). LC stage 
correlated significantly with an NRS-2002 score ≥ 3. It 
was also related to the length of patients’ in-hospital 
stay. CRC stage significantly positively correlated with 
blood lymphocyte count, and negatively with BMI, NRI 
and relative difference between actual and ideal body 
weight (Tab.2). 
Next, we analyzed factors influencing the occur-
rence of the measured outcomes (Tab.3). We found that 
only an NRS-2002 score ≥ 3 had a significant effect on 
the risk of in-hospital all-cause mortality, 14- and 30-day 
readmissions in patients with LC, and the risk of 14-day 
rehospitalization in patients with CRC. 
Discussion
The main rationale for this study was to check what is 
more important for patients nutritional risk, tumour size 
or its localization. To test this hypothesis we compared 
nutritional risk and prevalence of measured outcomes, 
related to nutritional risk among patients with LC and 
CRC. Moreover, in order to better evaluation of the clin-
ical importance of disease localization, we compared 
some clinical data between patients with LC and the 
other laryngeal disorders required hospitalization. This 
study, to the best of our knowledge, is the first compar-
ison of parameters of nutritional screening scores and 
nutritional status assessment parameters between pa-
tients with LC and CRC, the sixth and the second most 
common cancers in the world, respectively [17]. We 
found that patients with LC compared to individuals with 
CRC had significantly lower BMI values and a non-sig-
nificantly lower prevalence of body mass deficit (Tab. 
1). At the same time, they had a lower nutritional risk, 
expressed as an NRS-2002 score, and a lower absolute 
and relative difference between actual and ideal body 
weight (Tab. 1). Only 9% of our patients with LC had 
increased nutritional risk expressed as a score of at least 
Table 2. Spearman’s correlations of laryngeal cancer (LC) and colorectal cancer (CRC) clinical stage with selected 
parameters of nutritional screening and assessment 
Cancer stage correlation with LC (n = 33) CRC (n = 92)
R p < R p
Age -0.17 0.33 -0.02 0.84
Gender (female/male) -0.02 0.95 -0.1 0.36
In-hospital length of stay (days) 0.59 0.001 0.05 0.63
BMI (kg/m2) 0.10 0.64 -0.23 0.039
NRS-2002 score 0.32 0.08 0.23 0.07
NRS-2002 score ≥ 3 0.40 0.024 0.23 0.07
Relative difference between actual and ideal body weight (%) 0.02 0.91 -0.23 0.044
NRI 0.71 0.02 -0.45 0.035
Hemoglobin (g/dl) -0.28 0.23 -0.17 0.11
Total blood cholesterol (mg/dl) -0.04 0.95 0.05 0.88
Blood glucose (mg/dl) - 0.13 0.65 0.25 0.15
CRP (mg/dl) 0.37 0.47 0.12 0.46
Lymphocyte count (G/l) 0.14 0.77 0.44 0.019
Blood albumin (g/l) -0.35 0.056 0.10 0.63
CRP/albumin ratio 0.35 0.055 0.22 0.23
OPNI -0.35 0.056 -0.06 0.79
BMI — body mass index; NRS — Nutritional Risk Screening; NRI — Nutritional Risk Index; CRP — C-reactive protein; OPNI — Onodera’s (Preop-
erative) Prognostic Nutritional Index (OPNI)
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3 in the NRS-2002 questionnaire compared to 37% of 
individuals with CRC (Tab. 1). Other authors have shown 
that malnutrition prevalence among patients with head 
and neck cancers was greater than in our investigation 
and amounted to 30-50% [1, 6]. Kwag et al. reported 
a prevalence of malnutrition in patients with CRC in 
the Korean population at a level similar to ours [18]. 
However, other studies have shown that the prevalence 
of malnutrition among patients with CRC amounted to 
between 19.2% [19] and 30–60% [20]. Until now, only 
a few authors have compared the nutritional status of 
patients with neoplasms in different localizations. In 
a study by Du et al. [21], the proportions of patients 
with low blood levels of albumin, prealbumin, transfer-
rin, red blood cells, hemoglobin and hematocrit were 
higher for gastric cancer than for colon cancer, which 
was explained by the greater susceptibility of gastric 
patients to malnutrition and loss of fatty tissue. 
It is also known that hypoalbuminemia significantly 
increases the length of hospital stay, rates of surgical 
site infections, and the risk of enterocutaneous fistula 
formation and deep vein thrombosis, particularly in 
patients with CRC [22, 23]. Moreover, serum albumin 
was superior to prealbumin for predicting short-term 
recurrence in patients with operable CRC [24], and 
the morbidity and mortality rates in patients with CRC 
decreased by 7.3% and 15.6%, respectively, for each 
0.1 g/dl increase in preoperative serum albumin lev-
el.23 However, in our study, blood albumin concentra-
tion was similar both in patients with LC and CRC, as 
well as in the patients in the Department of Laryngol-
ogy without a diagnosis of laryngeal cancer (Tab. 1). 
In our patients with LC, blood albumin concentration 
correlated with neoplasm stage only with borderline 
statistical significance, similarly to derivative composed 
parameters, such as the CRP/albumin ratio and OPNI 
(Tab. 2). The last parameter, OPNI, which is the product 
of blood albumin concentration and lymphocyte count 
[11–15], linked LC with CRC because, in our patients 
with CRC, neoplasm advancement was associated with 
lymphocyte count, NRI and BMI (Tab. 2). 
It is known that a patient’s nutritional status, partic-
ularly malnutrition but also obesity, are common but 
poor prognosis factors in individuals with cancers in 
a number of localizations [1, 6, 20]. We also found that 
nutritional risk assessed using the NRS-2002 survey 
was related to an increased prevalence of the measured 
outcomes, such as patients’ in-hospital mortality and 
readmissions (Tab. 3). This demonstrates the necessity 
for further studies focused on the clinical importance of 
nutritional status assessment in patients with LC, as well 
as the need to evaluate the effectiveness of nutritional 
support and its financial impact on health services [6]. 
On the other hand, it should be underlined that, other 
than the NRS-2002, we did not find any single parameter 
of nutritional status assessment which related both to 
LC and CRC clinical stage (Tab. 2) and could be used 
to predict patients’ outcomes (Tab. 3). In our review 
of the literature, we did not find one recommended 
nutritional screening scores or nutritional assessment 
parameters dedicated to patients with LC either [5–7]; 
however, for patients with CRC, the most frequently 
used instruments for this purpose were as follows: the 
NRS-2002 [18-19], Malnutrition Universal Screening 
Tool (MUST), Subjective Global Assessment (SGA) [25, 
26], Patient-Generated Subjective Global Assessment 
(PG-SGA), NRI, and OPNI [11-15, 25, 26]. In the study 
by Kwag et al. [18], the NRS-2002 was an independent 
predictor of postoperative complications (OR 3.05; 
p = 0.045), such as anastomotic leakage and wound 
infection in patients with CRC. 
The practical importance of our observations is that 
both in patients with LC and CRC, nutritional screening 
and assessment should be performed using more than 
one diagnostic tool at the same time. This approach 
to patient management might potentially help identify 
patients with an increased risk of malnutrition and post-
operative complications. An increased NRS-2002 score 
may also identify those LC and CRC patients who might 
potentially benefit from nutritional support [27–30].
As with most authors, we could not avoid some 
methodological shortcomings that could have influ-
enced the strength of the deductions based on our 
results. The main limitation is a retrospective study 
design based on documentation analysis, although 
such a study design was described previously [4]. 
Moreover, our sample size was small, and we observed 
a low number of measured outcomes. It should also 
be taken into consideration that the clinical outcomes 
analyzed might be influenced by a number of factors 
other than nutritional status alone, e.g. main disease 
and comorbidity severity, which may also bias the re-
sults obtained. Such an observation is also justified by 
the analysis of Table 1, which shows an imbalance in 
potential confounding factors between groups, mainly 
concerning age, gender, and diabetes prevalence. 
Conclusions
The average nutritional risk in patients with laryn-
geal cancer amounted to 9% and was greater than 
in individuals with other conditions that required 
hospitalization in the Department of Otolaryngology 
but lower than in patients with CRC (37%). Nutritional 
risk diagnosed in patients with laryngeal cancer had 
a stronger association with the prevalence of the mea-
sured outcomes (in-hospital death, the risk of 14-day 
and 30-day readmission, length of hospitalization) than 
in individuals with colorectal cancer. However, due to 
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study limitations, the clinical significance of nutritional 
risk assessment in patients with LC and its financial 
impact on health services need further investigation.
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